FEATURED EDITORIAL
Discover how one research center, uniquely built for collaboration, enables the collection and analysis of high-quality specimens and data that will fuel both current and future research collaborations.
- 5 Takeaways From The Boston Open Science & Innovation Forum
- From "Live Drug" To Precision Tool: Redefining CAR T Safety
- NAMs In France And Europe: The Current Landscape
- Rethinking Tau Biology: The Future Of Neurodegenerative Drug Discovery
- Proteomics Biomarkers Beyond Blood
- MicroRNA Therapeutics In Metabolic Liver Disease: Context-Driven Drug Discovery
- Viral Coinfections: Emerging Challenges In Modern Drug Discovery
FEATURED APPLICATION CONTENT
-
Explore how leveraging expert CDMO partnerships can streamline the development process and enhance the efficacy of your bispecific antibody therapies.
-
Consider this alternative immunization approach — the PentaMice platform, a collection of five wildtype mouse strains bred in-house for increased MHC class II diversity — and how we're leveraging it for COVID-19 antibody discovery.
-
By forging strategic partnerships with comprehensive CDMOs, see how emerging biopharma firms can navigate through early-phase development and ensure a smooth transition to clinical advancement.
-
Explore how advanced single‑cell analysis links CAR localization, cell structure, and functional behavior, offering deeper insight into CAR T cell heterogeneity and performance.
-
Gain insight into automating DNA size selection that shows how optimized bead ratios and programmable handling improve fragment recovery, consistency, and throughput.
-
Gain insight into an automated high‑input workflow that streamlines long‑read whole‑genome library prep, supporting large DNA fragments while reducing reagent use.
-
A streamlined workflow reduces reagent use and hands‑on time while preserving long‑read sequencing quality. See how multiplexed offer an efficient option for scaling or mobilizing sequencing efforts.
-
Understanding covalent warhead kinetics is key to reducing safety risks early in discovery. Learn about a new approach to GSH‑based measurements that offers clearer predictors of toxicity.
-
See how a rapid digital PCR workflow enables reliable detection of trace RCL levels while maintaining strong performance in complex samples, which support more confident decisions in manufacturing.
-
Discover how mixed-mode chromatography enables high-yield purification of single-domain antibodies under mild conditions and why these approaches outperform traditional resins.
-
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Decoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.
- 5 Takeaways From The Boston Open Science & Innovation Forum
- Video Spotlight: Harvard's Alice Stanton On Engineering Integrated Human-Derived miBrain Organoid Models
- Insights From The Non-Opioid Pain Therapeutics Summit: Human-Centric Translational Models And The Reawakening Of Pain Pipelines
- Schrödinger's Equation Turns 100: How Quantum Chemistry Is Improving Drug Discovery
- Annual Reflections And Predictions From The Editors' Roundtable
FEATURED NEWS HEADLINES
- IBM Quantum Computer Accurately Simulates Real Magnetic Materials, Reproducing National Laboratory Data
- Purple Biotech Announces AI Collaboration With Converge Bio To Accelerate Development Of Its Next-Generation Tri-Specific Antibody Platform
- Xtressé™ Announces FDA IND Acceptance For Xvie, The First & Only Extracellular Vesicle Injectable Therapy For Androgenetic Alopecia
- Insilico Medicine And ASKA Pharmaceutical Expand Partnership To Discover Novel Targets For Women's Health
- Kelun-Biotech Receives IND Approval For SKB103, A Novel TAA-PD-L1 Bispecific ADC
- Quotient Therapeutics Announces Collaboration With Merck To Discover Novel Drug Targets In Inflammatory Bowel Disease Using Somatic Genomics Platform Technology
- Sinopia Biosciences Awarded NCI Grant To Advance LEADS Drug Discovery Platform For Oncology
- EndoCyclic Therapeutics Announces FDA Clearance Of Investigational New Drug (IND) Application For ENDO-205, A First-In-Class Non-Hormonal Precision Peptide Therapeutic For Endometriosis
- Ionis Announces Zilganersen New Drug Application For Alexander Disease (AxD) Accepted By FDA For Priority Review
- IntraBio Announces Submission Of Supplemental New Drug Application For Levacetylleucine For Ataxia-Telangiectasia
ARCHIVED NEWSLETTER
- 03.24.26 -- 5 Takeaways From The Boston Open Science & Innovation Forum
- 03.17.26 -- Hibernating Squirrels May Hold Clues To Treating Heart Failure
- 03.07.26 -- Drug Discovery Online Best Of February
- 03.03.26 -- In Vivo LNP-Engineered Cytokine-Armored CAR Cells For Solid Tumors
- 02.24.26 -- Small Molecule Enzyme Mimetics In Age-Related Neurodegeneration